Washington University School of Medicine
Biogen and Eisai’s Leqembi study shows nearly 83% of early Alzheimer’s patients remained stable or improved
The real-world findings support the long-term benefits of continuous treatment
Lilly and WHO Foundation partner to support global dementia action plan
The partnership will provide financial support and strengthen early detection and intervention efforts
Eli Lilly’s Alzheimer’s drug Kisunla shows growing benefit in long-term study
More than seven million people in the US are affected by the neurodegenerative disease
Biogen/Eisai’s Alzheimer’s drug Leqembi shows continued benefit over four years
An estimated 13 million people in the US will be living with Alzheimer’s disease by 2050
Roche shares promising data from Alzheimer’s disease development portfolio
The company is planning to initiate phase 3 studies of trontinemab in early AD this year
Ventyx’s investigational NLRP3 inhibitor shows promise in Parkinson’s disease
Planning is currently underway for a placebo-controlled trial of the candidate
Roche to advance Parkinson’s disease candidate into phase 3 development
More than ten million people worldwide are living with the neurodegenerative disorder
UKDRI researchers to evaluate new blood test for neurodegenerative disease diagnosis
It is hoped that the test could be available for widespread UK use in the coming years
Sanofi gains access to Alzheimer’s candidate through $470m Vigil acquisition
A phase 2 trial of the drug is expected to launch in the third quarter of this year
FDA approves Fujirebio’s Lumipulse as first Alzheimer’s disease blood test
The device offers a less invasive option compared to current PET scans and CSF tests
Biogen/Eisai’s Alzheimer’s disease drug Leqembi granted EC approval
The neurodegenerative disorder currently affects an estimated 6.9 million people in Europe
International Alzheimer’s disease prevention trial in at-risk young adults begins
The study will evaluate whether the amyloid beta protein can be blocked from ever accumulating in the brain